Author: Team

Woodstock, GA – June, 2011 – NeoMed, Inc. introduces the NeoBottle; the first closed-system container that combines collection, storage, fortification and delivery of fresh human breast milk (HBM) or enteral/oral liquids through a single device. Featuring collapsible floor technology and a unique airtight, leak-proof lid, the NeoBottle may extend the shelf life of fresh HBM or oral liquids by allowing users to evacuate excess air reducing the risks of oxidization and exposure to bacteria prior to delivery. Per the American Dietetic Association (ADA): “Fresh milk that is unit-dosed at time of expression may be held at refrigerated temperatures for up to 96 hours if expressed under clean conditions and the container is not entered prior to infant feeding. This is particularly important for small volume, fresh milk feedings for ill or preterm high-risk infants.”[1] The NeoBottle is specifically designed to meet this recommendation.

Tony Lair, President & CEO of NeoMed stated: “We recognize that proper handling is a critical component for preserving and delivering fresh HBM. Many preemie to micro-preemie patients rely on fresh HBM to mitigate dangerous feeding intolerances, gut diseases and notably NEC. This revolutionary new device provides a cost effective solution for mothers, clinicians and pharmacists to safely manage and preserve any type of oral liquid.”

[1] Infant feedings: Guidelines for Preparation of Human Milk and Formula in Health Care Facilities. Pediatric Nutrition Practice Group of the American Dietetic Association, 2011;4:47.

Woodstock, GA – May 2, 2011 – NeoMed announces that it has obtained CE Mark approval for its NeoMed Oral/Enteral Syringes and Dispensers. The CE Mark approval is a significant accomplishment that validates the quality of NeoMed products. NeoMed’s full line of Oral/Enteral Syringes and Dispensers will soon be available throughout Europe in both sterile and non-sterile packaging. This is a significant expansion from the current distribution in the United States and Canada. NeoMed is excited to expand its offerings globally to protect patients through safe administration practices with Oral/Enteral Syringes and Dispensers.

Tony Lair CEO & President of NeoMed, Inc. commented:

“Expanding our product line into Europe is another key milestone for NeoMed to become a leading manufacturer of enteral safety devices. We strive to provide superior products to clinicians to help promote the importance of enteral safety and to help mitigate risks to patients.”

NeoMed Oral/Enteral Syringes and Dispensers are designed to mitigate misconnection errors with enteral only, non-threaded connections that protect the patient while providing the highest level of care. Offered in 1ml, 3ml, 6ml, 12ml, 20ml, 35ml and 60ml sizes, these Oral/Enteral Syringes and Dispensers also feature precise pump compatibility, a self-righting tip cap, and are designed to meet the most rigorous compliance standards.

Woodstock, GA – NeoMed Inc. today announced that it was chosen for a new contract by Premier Purchasing Partners, LP, the group purchasing unit of Premier, Inc. The new agreement, effective October 1, 2010, provides Premier’s more than 2,400 member hospitals and 70,000 additional healthcare sites with access to contracts for NeoMed’s line enteral/oral syringes used in critical care environments and pharmacy pack oral syringes.

NeoMed’s acute care enteral/oral syringes offer Premier members pre-negotiated pricing and terms for a product line that is specifically designed to comply with new Joint Commission, FDA and ASPEN recommendations for enteral safety by protecting the patient from mis-connection errors. In the pharmacy, NeoMed’s dispensers offer enhanced safety features with the use of our self-righting tip cap and gradient markings designed to help protect against dosing errors.

Bethlehem, PA – Addressing a significant issue in neonatal healthcare while helping to also address Joint Commission Sentinel Event alerts, B. Braun Medical Inc. (B. Braun) announced today its alliance with NeoMed, Inc. – a manufacturer of medical devices specifically designed to enhance patient safety and clinical outcomes of the neonatal patient. The partnership, consisting of NeoMed^®’s Enteral Safety System and B. Braun’s Perfusor^® SPACE Syringe Pump, will help healthcare professionals prevent enteral/IV misconnections and medication errors. NeoMed and B. Braun showcased both products at the National Association of Neonatal Nurses (NANN) 26th Annual Education Conference.

“Catheter/tubing misconnections continue to contribute to serious, life threatening errors when clinicians mistakenly administer oral/enteral liquids through IV lines rather than through an enteral feeding tube,” said Gale White, Vice President of Infusion Systems Marketing for B. Braun Medical Inc. “The combination of both B. Braun’s Perfusor SPACE Syringe Pump and NeoMed’s Enteral Safety System promises the opportunity to provide healthcare professionals with a unique connector that allows for the safest, most accurate delivery of both enteral feedings and enteral medications. Perfusor SPACE Syringe Pump is the only syringe pump that recognizes 3 through 60cc NeoMed enteral syringes guaranteeing accuracy of flow at +/-2% using NeoMed syringes and extension sets.”
read more»

NeoMed, Inc. (Woodstock, GA) is pleased to announce 510(k) clearance from the FDA (Rockville, MD) for its new enteral only extension sets. The new extension set product line complements NeoMed’s comprehensive enteral safety system in delivering cost effective patient safety solutions. These products have a patent pending design with innovative features such as a unique tethered plug closure which provides better protection from exposure to ambient air and a male “step connector” that improves secure connections. To learn more about NeoMed, Inc. and our complete product line, please click here.

NeoMed, Inc. is pleased to announce that Health Canada has issued license approval for the following product families: syringes (oral/enteral and sterile), extension sets, feeding tubes, urinary drainage catheters and umbilical vessel catheters. Tony Lair, President and CEO of NeoMed issued the following statement: “We are excited to expand our product line into Canada and satisfy the growing international demands of the enteral safety market. Teaming with Equinox Specialty Products, Inc. in British Columbia facilitates our ability to provide a safe, comprehensive, and cost-effective solution to deliver our enteral safety system to the Canadian neonatal and pediatric population.

NeoMed Inc (Woodstock, GA) announced 510(k) clearance from the FDA (Rockville, MD) of its line of sterile oral/enteral syringes. The new sterile oral/enteral syringes complement NeoMed’s lines of clear, amber and bulk pharmacy pack oral dispensers. NeoMed also received a certification for the successful registration of its quality management system for sterile feeding tubes, extension sets, syringes, umbilical vessel catheters, and urinary drainage catheters to both the ISO 13485:2003 standard, and the requirements of the Canadian Medical Devices Conformity Assessment System (CMDCAS). The Canadian Medical Device Regulations require compliance with ISO 13485:2003 as well as regulations specific to Canada.

Smiths Medical (Saint Paul, MN) partnered with leading enteral syringe companies to allow Medfusion^® 3500 pumps to recognize NeoMed^®… enteral syringes, which will help reduce the risk of IV and enteral misconnections. Adding enteral syringe data to PharmGuard^® v5 software for Medfusion 3500 pumps allows clinicians to meet Joint Commission (Oakbrook Terrace, IL) requirements for enteral feedings, differentiate their patients’ IV and enteral lines, and help meet their facility’s needs by providing safe and accurate enteral delivery.

NeoMed Inc (Woodstock, GA) announced a recently released version 2.1 of its SafeBaby^® BreastMilk Tracking System. Software enhancements include improved comprehensive reporting and an updated user interface designed to improve speed and ease-of-use for technicians to clinicians. NeoMed is the only device manufacturer that has combined enteral delivery devices (i.e. feeding tubes, enteral syringes) and breastmilk tracking technology confirming that enteral misconnections and mis-feeds are eliminated. For further information, please visit www.safebabybmt.com.

Novation LLC (Irving, TX), the supply contracting company of VHA Inc (Irving, TX), University HealthSystem Consortium (UHC) (Oak Brook, IL) and Provista (Irving, TX), awarded a contract to Neomed Inc (Woodstock, GA) for Neomed’s line of enteral/oral syringes. This agreement was awarded under Novation’s New Technology program and highlights Neomed’s innovative, enteral only, design that includes a 2D barcode on the barrel of the syringe facilitating device and content tracking. NeoMed’s products are at the core of ensuring patient safety by avoiding dangerous mis-connection and dosing errors. The agreement is effective beginning July 1, 2009.